These findings demonstrate the prognostic importance of immunosuppressive macrophages in locally advanced prostate tumors, with intriguing findings that the level of infiltration of CD163+ macrophages in tumor‐adjacent normal‐like epithelium is the strongest independent predictor of adverse clinical outcomes. The gene discussed is CD163; the disease is prostate neoplasm.